Day: October 6, 2020

Forget Livongo: This Is a Better Telehealth Stock

It makes sense as an investor to follow trends (to an extent!). Telehealth is definitely a concept that has grown in popularity because of the COVID-19 pandemic, and the trend will likely continue to expand after coronavirus fears are gone.

Telehealth makes sense from a lot of angles, even in a world without the concern of catching coronavirus in a doctor’s office. Insurance companies like telehealth because it cuts down on costs associated with having to go to a doctor’s office or hospital for basic medical care. Patients see telehealth visits as more convenient than schlepping across town to cool their heels reading two-year-old magazines while waiting for an appointment. 

According to a 2018 report, telehealth is expected to be a $185 billion market by 2026. Two things making telehealth more effective are better remote monitoring devices and improved telecommunication technology, such as 5G internet speeds.

Young woman looking at her cell phone.

Image source: Getty Images.

Read More

Apple Fitness Plus vs. Peloton: Which streaming workout service is better?



If you like working out with an Apple Watch, but wish it offered more exercise guidance, you’re getting your wish this year. Announced on Tuesday, Apple Fitness Plus is a monthly service that gives you unlimited access to workout classes spanning the most popular genres, from HIIT to yoga and rowing to cycling. It connects to your Apple Watch to record your heart rate, pace and calories burned during your class, and show you those metrics in real time on whatever screen you use to follow the workout.

Fitness Plus puts Apple in direct competition with many other workout streaming services, such as Peloton, Daily Burn and Glo, which provide a variety of on-demand video fitness classes. While none of those connect directly to an Apple Watch to show you real-time stats on the screen, many will connect to a heart-rate monitor to show your heart rate

Read More

A new discovery in regenerative medicine


IMAGE: In vitro culture of induced trophoblast stem cells (pink) wrapping clusters of naive induced pluripotent stem cells (cyan)
view more 

Credit: (C) Monash Biomedicine Discovery Institute

An international collaboration involving Monash University and Duke-NUS researchers have made an unexpected world-first stem cell discovery that may lead to new treatments for placenta complications during pregnancy.

While it is widely known that adult skin cells can be reprogrammed into cells similar to human embryonic stem cells that can then be used to develop tissue from human organs – known as induced pluripotent stem cells (iPSCs) – the same process could not create placenta tissue.

iPSCs opened up the potential for personalised cell therapies and new opportunities for regenerative medicine, safe drug testing and toxicity assessments, however little was known about exactly how they were made.

An international team led by ARC Future Fellow Professor Jose Polo from Monash University’s Biomedicine Discovery

Read More